8 July, 2021, by ClinCaptureUser
ClinCapture is excited to announce additional features in Captivate® 3.7. The latest release is available to current and new customers. It includes enhancements to medical coding, secure data deletion, and enhancements to change reports.
Medical Coding Support for CTCAE 5.0 Oncology
Captivate® Coder has been updated to support the latest version of the Common Terminology Criteria for Adverse Events (CTCAE). Customers running oncology studies have access to the most recent adverse event data when using our medical coding module.
Secure Data Deletion Option
Captivate® EDC is validated and allows our customers to be fully FDA 21 CFR Part 11 compliant, ensuring data integrity and security. We’ve added additional options for user management which allow for greater flexibility in user regulation.
Enhancements to Change Reports
Change reports in Captivate® allow you to see exactly what’s being promoted from your test environment to a secondary study. We’ve added a summary cover page to change reports to make it easier to identify which studies the report was generated for and when the change report was generated.
To learn more about our latest release or to upgrade your study, please contact your ClinCapture account manager.
8 March, 2022
Why Customers Love ClinCapture’s Ease of UseRecently we spoke to customers about their experience using ClinCapture’s Electronic Data Capture (EDC) and Virtual Data Capture® (VDC®) eClinical systems. Although there are a multitude of reasons Sponsors and CROs decide to partner with ClinCapt
9 February, 2022
How to Pick a Successful EDC Partner as a CROBeing a CRO is no easy feat. In the ever-changing world of clinical research, today’s CROs encounter endless twists and turns in study requirements and logistics. Finding a suitable EDC partner that fits the needs of your Sponsor clients’ studies is crucial to the success of a lasting relationship with your clients. Although no two studies are exactly alike, her
17 March, 2021
What is eConsent and what are the benefits?What is eConsent? The Food and Drug Administration has defined electronic informed consent (eConsent) as “the use of electronic systems and processes that may employ multiple electronic media, including text, graphics, audio, video, podcasts, passive and interactive Web sites, biological recognition devices, and card readers, to convey information related to the study to obta